In Parkinson’s disease, GPR37 misprocessing contributes to ER stress and dopaminergic neurodegeneration, while in multiple sclerosis and stroke, its dysregulation alters myelin repair and neurogenic responses. This evidence concerns the gene GPR37 and Parkinson disease.